FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: ophthalmic drops contain mixture of 0.1 wt. -% of glycoseaminoglycans isolated from human placenta as an active substance, 2 wt. -% of polyvinylpyrrolidone, and physiological solution, the balance. Proposed ophthalmic drops provide effective healing and reduced time of treatment. EFFECT: enhanced effectiveness of ophthalmic drops. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC FILM | 2005 |
|
RU2286170C1 |
OPHTHALMIC DROP | 1999 |
|
RU2163123C2 |
EYE DROPS | 1994 |
|
RU2088215C1 |
EYEGEL | 1994 |
|
RU2098079C1 |
OCULAR OINTMENT | 1994 |
|
RU2082434C1 |
PREPARATION FOR DIAGNOSIS OF DISEASES AND TRAUMAS OF EYE CORNEA | 1995 |
|
RU2142292C1 |
EYE OINTMENT | 1994 |
|
RU2094060C1 |
EYE FILM | 1997 |
|
RU2173178C2 |
AGENT FOR TREATMENT OF TRAUMATIC INFECTIONS OF EYE ANTERIOR PART | 1996 |
|
RU2142288C1 |
PREPARATION FOR DIAGNOSIS OF EYE CORNEA ILLNESS AND TRAUMA | 1995 |
|
RU2098089C1 |
Authors
Dates
2003-11-20—Published
2002-02-26—Filed